By Deandra Grant & Griffin Grant

Welcome to The Defense File where we examine the criminal cases of public figures through the lens of Texas criminal law. Each entry looks at what happened in court, what the defense argued, and what a defendant would have faced (and how they might have been defended) if the same facts had occurred in Texas.

The IncidentsTodd Helton: Rockies Legend’s Legal Troubles

Todd Helton’s legal troubles span two DUI arrests in different states, a hit-and-run misdemeanor in between, and a defense in the second DUI case that raises one of the most medically and legally interesting questions in impaired driving law: can a person be impaired by a prescription sleep medication they took hours earlier without knowing they were still affected?

The 2013 Colorado DUI

On February 6, 2013 (before what would be his final MLB season) Helton was pulled over near Denver for erratic driving. Officers noted signs of intoxication. He was charged with DUI and careless driving. He pleaded guilty and received one year of probation, a $400 fine, 24 hours of community service, and mandatory alcohol education classes. No jail time was imposed. Helton cooperated and the case resolved without significant fanfare.

The 2017 Hit-and-Run

On August 30, 2017, Helton’s pickup truck struck two unoccupied vehicles at Greystone Summit Apartments in Knoxville, Tennessee. He left his name with one vehicle owner but did not remain at the scene as required. He was cited for a misdemeanor. The charge was dismissed on October 4, 2018, after he paid court costs and restitution. His attorney confirmed the charge was expunged.

The 2019 Tennessee DUI: The Ambien Case

On March 18, 2019, Helton crashed his pickup truck into a telephone pole in Knox County, Tennessee. Officers responded and noted a cup in the vehicle smelling of alcohol. Helton told officers he had taken Ambien (the brand name for zolpidem, a prescription sleep medication) approximately four hours before the crash. He required emergency medical care but no other vehicles were involved.

Helton pleaded guilty to first-offense DUI on March 11, 2020, and received 48 hours in jail, 11 months and 29 days of unsupervised probation, a $350 fine, a one-year license suspension, and attendance at a Victim Impact Panel. His attorney stated that Helton had completed treatment and expressed remorse.

The Texas Analysis

Two separate issues make the Texas analysis distinctive here. First, the Ambien claim in the 2019 case raises the prescription drug DWI framework in a way that could have produced a very different defense strategy in Texas. Second, if both DUIs had occurred in Texas, the 2019 arrest would have been a second-offense Class A misdemeanor with a mandatory minimum 30-day jail sentence and not the 48-hour sentence Helton received in Tennessee.

The Ambien Case: Prescription Drug DWI in Texas

Texas Penal Code §49.04 defines DWI to include operating a motor vehicle while not having the normal use of mental or physical faculties by reason of the introduction of alcohol, a controlled substance, a drug, a dangerous drug, or a combination of substances. Zolpidem (Ambien) is a Schedule IV controlled substance under the Texas Controlled Substances Act. A person impaired by zolpidem while driving can be charged with DWI in Texas regardless of whether any alcohol is involved.

Helton’s claim (that he took Ambien four hours before the crash and believed it had worn off) raises two Texas-specific legal questions that the Tennessee case never fully developed.

Presence vs. Impairment: The Central Defense Argument

The most important distinction in any prescription drug DWI case is between the presence of a substance in the body and actual impairment of normal faculties at the time of driving. These are different questions. Zolpidem is metabolized relatively quickly. Its half-life is approximately 2 to 3 hours so it takes 10 to 12 hours to clear the system, though it may take 24 to 48 hours for some.  A blood test showing detectable zolpidem concentration four or more hours after ingestion does not, by itself, establish impairment at the level required for a DWI conviction.

In Texas, there is no per se legal limit for zolpidem or any other prescription medication. The prosecution must prove actual impairment of normal mental or physical faculties. That requires showing that Helton’s ability to safely operate a vehicle was compromised by the drug at the time he was driving and not merely that the drug was present in his system. The defense would retain a pharmacology expert to evaluate the blood concentration, the timing of the dose, and whether the measured level was consistent with actual cognitive impairment or with residual metabolite without active effect.

Deandra Grant’s Master’s Degree in Pharmaceutical Science and Graduate Certificate in Forensic Toxicology apply directly to this analysis. Zolpidem pharmacokinetics (absorption rate, peak concentration timing, elimination half-life, and the relationship between blood concentration and behavioral impairment) are pharmaceutical science questions that require graduate-level training to address at the expert witness level.

The FDA Black Box Warning: Sleep-Driving

Helton’s claim that he took Ambien four hours before the crash and did not remember driving is not as implausible as it might initially sound. Zolpidem carries an FDA black box warning (the most serious category of warning) specifically addressing “complex sleep behaviors” including sleep-driving: getting into a vehicle and driving while not fully awake, with no memory of the episode afterward.

The FDA’s warning acknowledges that sleep-driving and other complex behaviors have been reported with zolpidem use even when the drug is taken as prescribed, and that the risk is higher when zolpidem is combined with alcohol or other CNS depressants. If Helton both took Ambien and consumed alcohol (which the officers’ observation of the cup in the vehicle suggests) the combination would significantly elevate both the impairment risk and the likelihood of a documented complex sleep behavior episode.

This creates a genuine factual defense question: did Helton consciously drive to a location and then crash, or did he experience a zolpidem-induced complex sleep behavior with no contemporaneous awareness?

The Repeat Offense Enhancement: What the 2019 Arrest Would Have Been in Texas

If both of Helton’s DUI incidents had occurred in Texas, the 2019 arrest would not have been a first-offense case. His 2013 conviction would have been a prior DWI conviction for enhancement purposes under Texas Penal Code §49.09.

A second DWI conviction in Texas is a Class A misdemeanor, carrying:

  • Mandatory minimum: 30 days in county jail if not placed on probation. 72 hours to 30 days in jail as a condition of probation.
  • Maximum: 1 year in county jail.
  • Fine: Up to $4,000.
  • License suspension: 180 days to 2 years.

Helton received 48 hours in jail in Tennessee on what was treated as a first-offense DUI.

The 2017 Hit-and-Run: Texas Transportation Code

Helton’s 2017 hit-and-run misdemeanor in Tennessee involved striking unoccupied vehicles and leaving without fully complying with reporting requirements. Texas Transportation Code §550.024 requires a driver involved in an accident resulting in damage to an unattended vehicle to immediately stop, locate the owner if possible, and leave written notice with the vehicle. Failure to comply is a Class C misdemeanor.

The Tennessee charge was resolved with payment of costs and restitution, and expunged. In Texas, the same conduct would likely result in a Class C misdemeanor citation (fine-only, no jail) provided the damage was to unoccupied vehicles only. The Texas expunction laws would similarly allow expunction of a Class C misdemeanor conviction under the right circumstances, and in a case resolved through dismissal after payment, expunction under Texas Code of Criminal Procedure Art. 55.01 would likely be available.

How Would the Defense Approach the Ambien Case in Texas?

  • Pharmaceutical science challenge to the impairment evidence. The timing of the dose, the blood concentration at the time of the crash, and whether that concentration was consistent with active impairment or residual elimination-phase metabolite are expert witness questions. The defense retains a pharmacologist or forensic toxicologist to evaluate the data.
  • Sleep-driving defense development. The FDA black box warning documentation, any prior history of complex sleep behaviors with zolpidem, the combination with alcohol as an FDA-identified risk factor, and any evidence that Helton had no contemporaneous awareness of driving are all developed for trial.
  • Negotiate the prior conviction’s applicability. Texas requires proof of the prior conviction beyond a reasonable doubt at the punishment phase. The out-of-state Colorado conviction must be authenticated. If authentication is defective, the enhancement may not stand, and the 2019 case might be triable as a first offense with the lower punishment range and more favorable sentencing options.
  • HB 3582 deferred adjudication — evaluate applicability. Under the 2023 amendment, deferred adjudication is available for a first-offense DWI with no prior DWI convictions and a recorded BAC below 0.15%. If the prior Colorado conviction cannot be authenticated or is otherwise challenged, and if Helton’s BAC is at or below the threshold, deferred adjudication becomes the defense’s primary negotiating target for the drug charge in the 2019 case.

What This Case Illustrates

The Helton cases illustrate two issues that arise more often in Texas DWI practice than most people realize. First, prescription drug DWI (particularly cases involving sleep medications with documented complex-behavior side effects) presents genuinely difficult questions about the nature of impairment. Second, the Texas repeat-offense enhancement structure imposes consequences that are meaningfully more serious than first-offense resolution in ways that differ substantially from state to state.

A defendant who has a prior out-of-state DUI, believes they are facing a first-offense charge in Texas, and accepts a plea without investigating the prior conviction’s enhancement applicability may be accepting a Class A misdemeanor sentence with a 30-day mandatory minimum when they could have litigated the enhancement. That authentication question is worth examining in every Texas DWI case with an out-of-state prior.

Sources

  • Denver Post — Helton 2013 DUI arrest: denverpost.com
  • Knoxville News Sentinel — Helton 2019 DUI arrest and guilty plea: knoxnews.com
  • Knox County Court records — State of Tennessee v. Todd Helton (2020)
  • FDA — Ambien (zolpidem) prescribing information and black box warning on complex sleep behaviors: fda.gov
  • Texas Penal Code §49.04 and §49.09 — DWI and enhancement: statutes.capitol.texas.gov
  • Texas Penal Code §8.01 and §8.04 — Insanity and voluntary intoxication: statutes.capitol.texas.gov
  • Texas Transportation Code §550.024 — Duty to give information after striking unattended vehicle: statutes.capitol.texas.gov
  • The Defense File is an educational series. All Texas analysis is hypothetical and does not constitute legal advice about any specific case.

If you are facing DWI charges in Texas involving prescription medications, or if you have an out-of-state prior DWI and need to understand your exposure in Texas, call (214) 225-7117 for a free, confidential consultation. Or schedule online at texasdwisite.com.